Hear-The-Journey Speaker

A/Prof Tan Ker Kan

  • Head & Senior Consultant, Division of Colorectal Surgery, Department of Surgery, National University Hospital
  • Senior Consultant, Division of Surgical Oncology, National University Cancer Institute, Singapore
  • Associate Chairman, Medical Board (Research), National University Hospital
  • Assistant Dean (Research), Yong Loo Lin School of Medicine, National University of Singapore
  • Senior Consultant, Colorectal Cancer Tumour Group, NCIS
  • Associate Professor, Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore

Dr Tan Ker Kan is currently the head of the Division of Colorectal Surgery in NUH and is holding several other administrative positions in NUH and NUSMed. Of relevance to today’s presentation, he was awarded the HSRG back in 2017 and then the CSA in 2019 and is the theme PI for our NUHS Centre Grant for population health known as SPHERIC. He has also completed his PhD in Saw Swee Hock School of Public Health back in 2018/2019.  He has published several papers over the years and aside from collaborating with basic scientists, he is also delving into HSR and Population Health research.

A/Prof Toh Han Chong

  • Deputy Medical Director, NCCS
  • Associate Professor, Cancer & Stem Cell Biology Program and SingHealth-Duke Global Health Institute, Duke-NUS

Dr Toh Han Chong is Deputy Medical Director, National Cancer Centre Singapore (NCCS), Associate Professor at the Cancer & Stem Cell Biology Program and SingHealth-Duke Global Health Institute, Duke-NUS.

Dr Toh completed his International Baccalaureate Diploma at the Lester B. Pearson United World College in British Columbia Canada. He graduated from the University of London, UK, with an Intercalated Bachelor of Science in ‘Infection and Immunity’ from St Mary’s Hospital Medical School and qualified as a medical doctor from University of Cambridge, United Kingdom. Dr Toh obtained his Fellowship of the Royal College of Physicians in 2003. He received his medical oncology fellowship training at the Singapore General Hospital, and at the Massachusetts General Hospital, Harvard Medical School, Boston, USA. He then completed a research fellowship in cancer immunotherapy at the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA.

Dr Toh received the National Outstanding Clinician Scientist Award 2018 for developing and building a cancer immunotherapy programme in Singapore. Dr Toh is founding chairman of the Singapore Cancer Immunotherapy Consortium, founding Chief Medical Officer of Tessa Therapeutics Ltd and on the Cancer Immunotherapy faculty of the European Society of Medical Oncology. He leads a National Large Collaborative Grant on virus-driven cancers prevalent in Asia. He has published over 120 peer review papers including in the New England Journal of Medicine, Nature Reviews Clinical Oncology, Nature Genetics, Lancet Oncology, Journal of Clinical Oncology, Journal of Clinical Investigation, Journal of Hepatology, Molecular Therapy, Clinical Cancer Research and Cancer Gene Therapy.

NCAM 2021 Digital Meeting Main Conference

Theme: Targeting the Untargetable

30 July - 31 July 2021